Cronos Group Inc. (CRON)

USD 1.84

(-1.6%)

Total Debt Summary of Cronos Group Inc.

  • Cronos Group Inc.'s latest annual total debt in 2023 was 2.53 Million USD , down -34.47% from previous year.
  • Cronos Group Inc.'s latest quarterly total debt in 2024 Q2 was 1.99 Million USD , down -11.84% from previous quarter.
  • Cronos Group Inc. reported annual total debt of 3.87 Million USD in 2022, down -60.47% from previous year.
  • Cronos Group Inc. reported annual total debt of 9.8 Million USD in 2021, down -0.08% from previous year.
  • Cronos Group Inc. reported quarterly total debt of 2.26 Million USD for 2024 Q1, down -11.0% from previous quarter.
  • Cronos Group Inc. reported quarterly total debt of 2.53 Million USD for 2023 Q4, down -6.03% from previous quarter.

Annual Total Debt Chart of Cronos Group Inc. (2023 - 2013)

Created with Highcharts 11.1.0YearsTotal Debt201320142015201620172018201920202021202220230 USD5000000 USD10000000 USD15000000 USD20000000 USD

Historical Annual Total Debt of Cronos Group Inc. (2023 - 2013)

Year Total Debt Total Debt Growth
2023 2.53 Million USD -34.47%
2022 3.87 Million USD -60.47%
2021 9.8 Million USD -0.08%
2020 9.81 Million USD 38.09%
2019 7.1 Million CAD -53.8%
2018 15.38 Million CAD 260.41%
2017 4.26 Million CAD 43.42%
2016 2.97 Million CAD 163.88%
2015 1.12 Million CAD 1038.43%
2014 99.06 Thousand CAD 0.0%
2013 - CAD 0.0%

Peer Total Debt Comparison of Cronos Group Inc.

Name Total Debt Total Debt Difference
ANI Pharmaceuticals, Inc. 315.32 Million USD 99.195%
Aquestive Therapeutics, Inc. 98.82 Million USD 97.43%
Collegium Pharmaceutical, Inc. 674.28 Million USD 99.623%
Cosmos Health Inc. 12.42 Million USD 79.556%
Cyclo Therapeutics, Inc. 1.03 Million USD -145.852%
Esperion Therapeutics, Inc. 540.94 Million USD 99.53%
Incannex Healthcare Limited 373 Thousand USD -580.949%
Kala Pharmaceuticals, Inc. 36.32 Million USD 93.007%
Lifecore Biomedical, Inc. 130.36 Million USD 98.052%
Regencell Bioscience Holdings Limited 59.8 Thousand USD -4146.891%
Sunshine Biopharma, Inc. 657.7 Thousand USD -286.182%
Sunshine Biopharma, Inc. 657.7 Thousand USD -286.182%
SCYNEXIS, Inc. 15.08 Million USD 83.157%
Safety Shot Inc 1.54 Million USD -63.976%
Theratechnologies Inc. 58.96 Million USD 95.693%
Alpha Teknova, Inc. 30.45 Million USD 91.661%
Universe Pharmaceuticals INC 5.48 Million USD 53.672%
Pacira BioSciences, Inc. 586.04 Million USD 99.567%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD -317.753%
Dynavax Technologies Corporation 256.91 Million USD 99.011%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 99.645%
Radius Health, Inc. 365.31 Million USD 99.305%
China SXT Pharmaceuticals, Inc. 2.64 Million USD 4.061%
Alvotech 1.07 Billion USD 99.764%
Intra-Cellular Therapies, Inc. 16.93 Million USD 85.004%
SIGA Technologies, Inc. 1.46 Million USD -73.492%
Shineco, Inc. 29.65 Million USD 91.435%
Silver Spike Investment Corp. - USD -Infinity%
Journey Medical Corporation 17.73 Million USD 85.674%
Petros Pharmaceuticals, Inc. 8.27 Million USD 69.312%
Embecta Corp. 1.63 Billion USD 99.845%
Harrow Health, Inc. 190.5 Million USD 98.667%
Procaps Group, S.A. 285.93 Million USD 99.112%
Biofrontera Inc. 5.39 Million USD 52.955%
DURECT Corporation 20.74 Million USD 87.757%
PainReform Ltd. 86 Thousand USD -2853.416%
Supernus Pharmaceuticals, Inc. 41.52 Million USD 93.884%
OptiNose, Inc. 131.74 Million USD 98.072%
RedHill Biopharma Ltd. 1.17 Million USD -116.532%
Organogenesis Holdings Inc. 119.35 Million USD 97.872%
Cumberland Pharmaceuticals Inc. 18.42 Million USD 86.217%
ProPhase Labs, Inc. 21.38 Million USD 88.12%
Phibro Animal Health Corporation 525.45 Million USD 99.517%
Procaps Group S.A. 285.93 Million USD 99.112%
TherapeuticsMD, Inc. 8 Million USD 68.271%
Viatris Inc. 18.12 Billion USD 99.986%
Rockwell Medical, Inc. 13.43 Million USD 81.1%
Aytu BioPharma, Inc. 15.12 Million USD 83.211%
Tilray Brands, Inc. 387.31 Million USD 99.344%
PetIQ, Inc. 468.3 Million USD 99.458%
Talphera, Inc. - USD -Infinity%
Neurocrine Biosciences, Inc. 428.4 Million USD 99.407%
Alimera Sciences, Inc. 67.39 Million USD 96.231%
Assertio Holdings, Inc. 40.91 Million USD 93.792%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD -133.516%
Avadel Pharmaceuticals plc 35.38 Million USD 92.822%
Hempacco Co., Inc. 13.72 Million USD 81.493%
Alvotech 1.07 Billion USD 99.764%
Lantheus Holdings, Inc. 616.94 Million USD 99.588%
Kamada Ltd. 8.74 Million USD 70.969%
Currenc Group, Inc. 31.94 Million USD 92.049%
Indivior PLC 281.6 Million USD 99.098%
Evoke Pharma, Inc. 5 Million USD 49.201%
Flora Growth Corp. 3.67 Million USD 30.83%
Cyclo Therapeutics, Inc. 1.03 Million USD -145.852%
Evolus, Inc. 126.54 Million USD 97.993%
HUTCHMED (China) Limited 86.13 Million USD 97.051%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 99.593%
Akanda Corp. 3.99 Million USD 36.482%